PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (8)
2024
-
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554
2020
-
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 4, pp. 762-768
2018
-
Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas
British Journal of Dermatology
-
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study
Clinical and Experimental Dermatology, Vol. 43, Núm. 2, pp. 137-143
2014
-
PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases
PLoS ONE, Vol. 9, Núm. 11
-
Rituximab in the treatment of primary cutaneous B-cell lymphoma: A review
Actas Dermo-Sifiliograficas
2013
-
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
Haematologica, Vol. 98, Núm. 1, pp. 57-64
2012
-
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
British Journal of Dermatology, Vol. 167, Núm. 1, pp. 174-179